+Compare
IHE
ETF ticker: NYSE ARCA
AS OF
Loading...
Price
Loading...
Change
Loading...
Net Assets
587.63M

IHE iShares US Pharmaceuticals ETF Forecast, Technical & Fundamental Analysis

Category Health
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for IHE with price predictions
07:00 PM EST Dec 06, 2023

IHE's RSI Indicator recovers from oversold territory

The RSI Oscillator for IHE moved out of oversold territory on November 02, 2023. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 24, 2023. You may want to consider a long position or call options on IHE as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for IHE just turned positive on November 06, 2023. Looking at past instances where IHE's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

IHE moved above its 50-day moving average on November 30, 2023 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IHE crossed bullishly above the 50-day moving average on December 04, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IHE advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 263 cases where IHE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The 50-day moving average for IHE moved below the 200-day moving average on November 13, 2023. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IHE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IHE broke above its upper Bollinger Band on December 04, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NASDAQ:LLY), Johnson & Johnson (NASDAQ:JNJ), Merck & Co (NASDAQ:MRK), Pfizer (NASDAQ:PFE), Bristol-Myers Squibb Co (NASDAQ:BMY), ZOETIS (NASDAQ:ZTS), Elanco Animal Health (NASDAQ:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

Market Cap

The average market capitalization across the iShares US Pharmaceuticals ETF ETF is 55.15B. The market cap for tickers in the group ranges from 61.62M to 561.54B. LLY holds the highest valuation in this group at 561.54B. The lowest valued company is ACRS at 61.62M.

High and low price notable news

The average weekly price growth across all stocks in the iShares US Pharmaceuticals ETF ETF was 53%. For the same ETF, the average monthly price growth was 118%, and the average quarterly price growth was 107%. ARVN experienced the highest price growth at 49%, while PFE experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the iShares US Pharmaceuticals ETF ETF was -25%. For the same stocks of the ETF, the average monthly volume growth was 7% and the average quarterly volume growth was 82%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 61
Price Growth Rating: 60
SMR Rating: 71
Profit Risk Rating: 73
Seasonality Score: 23 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCUEX16.850.07
+0.42%
MainStay PineStone U.S. Equity A
CBFFX34.840.13
+0.37%
American Funds Global Balanced 529F1
MGLMX16.200.03
+0.19%
MFS Global Real Estate R4
BCSCX7.590.01
+0.11%
BlackRock Commodity Strategies Inv C
TYWIX10.41N/A
N/A
AMG GW&K Emerging Wealth Equity Z

IHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, IHE has been closely correlated with VHT. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if IHE jumps, then VHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IHE
1D Price
Change %
IHE100%
-0.25%
VHT - IHE
84%
Closely correlated
-0.09%
XLV - IHE
83%
Closely correlated
-0.12%
IBB - IHE
69%
Closely correlated
+0.71%
XBI - IHE
54%
Loosely correlated
+1.23%
IHI - IHE
53%
Loosely correlated
+0.30%